drugset / Trial / NCT00976872

Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins

NCT00976872

Completed 52 enrolled Assaf-Harofeh Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Recent evidences showed beneficial effects of omega-3 fatty acids on cardiovascular morbidity and mortality. Regular Omega-3 fatty acid consumption reduces cardiovascular mortality, ischemic heart disease and stroke mortality. There is probably no single mechanism of action that explains this beneficial effect; but possible mechanisms include reduce susceptibility of the heart to ventricular arrhythmia, antithrombogenic effect, reduce triglyceride level, promotion of nitric oxide-induced endothelial relaxation, and retard growth of atherosclerotic plaque. The combination of satins and omega3 was proved to be better the any of the drugs alone in several studies. The purpose of the study is to investigate several possible mechanisms that may explain the add on beneficial effect of omega-3 in hypercholesterolemic patients already treated with satins.

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DOCONEXENT Other / unclassified 810 mg
Subject Eicosapentaenoic acid Small molecule 1084 mg

Indications

No indication recorded.